Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood (2021) 137 (6): 751–762.

https://doi.org/10.1182/blood.2020007732

Published: 2021

Includes: Supplemental data

Journal Articles

Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study

Rachael F. Grace, MD, D. Mark Layton, MB BS, FRCP, FRCPCH, Frédéric Galactéros, MD PhD, Wilma Barcellini, MD, Eduard J. van Beers, MD PhD, Hassan M. Yaish, MD, Yaddanapudi Ravindranath, MBBS, Kevin H. M. Kuo, MDMSc,FRCPC, Sujit Sheth, MD, Janet L. Kwiatkowski, MD MSCE, Lei Hua, PhD, Peter F. Hawkins, PhD, Chris Mix, MD, Bertil Glader, MD PhD

Blood (2019) 134 (Supplement_1): 3512.

https://doi.org/10.1182/blood-2019-123406

Published: 2019

Journal Articles

Extracorporeal Photopheresis Is Effective in Treating Graft-Versus-Host Disease: A Retrospective Analysis

Manasa Reddy, MD, Madhuri Vusirikala, MD, Nicole De Simone, MDMPH, Ravi Sarode, MD

Blood (2016) 128 (22): 5797.

https://doi.org/10.1182/blood.V128.22.5797.5797

Published: 2016

Journal Articles

Predictors for Steroid Tapering in Patients with Acute Graft-Versus-Host Disease and Their Impact on Graft-Versus-Host Disease Response and Non-Relapse Mortality: Older Age and Co-Morbidities Are Associated with Quicker Tapering and Worse Outcomes

Blood (2016) 128 (22): 3424.

https://doi.org/10.1182/blood.V128.22.3424.3424

Published: 2016

Journal Articles

Plasma Exchange Taper for Acquired TTP Is Protective Against Recurrence at Both 30 Days and 6 Months: A Retrospective Study from 2 Academic Medical Centers

Phillip Chae, MD, Jay S Raval, MD, Darla Liles, MD, Yara S Park, MD, Marshall A. Mazepa, MD

Blood (2015) 126 (23): 1046.

https://doi.org/10.1182/blood.V126.23.1046.1046

Published: 2015

Journal Articles

Tapering Eltrombopag in Patients with Chronic ITP: How Successful Is This and in Whom Does It Work?

James B. Bussel, MD, Shah N. Mahmud, Sophie L Brigstocke, Sarah M Torneten, M.A.

Blood (2015) 126 (23): 1054.

https://doi.org/10.1182/blood.V126.23.1054.1054

Published: 2015

Journal Articles

A Bayesian, Phase II Randomized Trial of Extracorporeal Photopheresis (ECP) Plus Steroids Versus Steroids-Alone in Patients with Newly Diagnosed Acute Graft Vs. Host Disease (GVHD): The Addition of ECP Improves Gvhd Response and the Ability to Taper Steroids

Blood (2015) 126 (23): 854.

https://doi.org/10.1182/blood.V126.23.854.854

Published: 2015

Journal Articles

Immunosuppression Taper to Induce Graft-Verus-Tumor Activity As the Sole Therapy for Early Relapse after Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

Natasha Kekre, MD FRCPC, Haesook T. Kim, PhD, Gita Thanarajasingam, MD, Philippe Armand, MD PhD, Joseph H Antin, MD, Corey S Cutler, MD MPH, Sarah Nikiforow, MD PhD, Vincent T. Ho, MD, Edwin P. Alyea, MD, John Koreth, MBBS, DPhil, Robert J. Soiffer, MD

Blood (2014) 124 (21): 2504.

https://doi.org/10.1182/blood.V124.21.2504.2504

Published: 2014

Journal Articles

A Final Analysis of a Phase 2, Single-Arm Study of Platelet (Plt) Responses and Remission Rates in Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim

Adrian Newland, Bertrand Godeau, Victor Priego, Jean-Francois Viallard, Maria Fernanda Lopez Fernandez, Amelia Orejudos, Angela Lopez

Blood (2014) 124 (21): 2775.

https://doi.org/10.1182/blood.V124.21.2775.2775

Published: 2014

Journal Articles

Sequential Intensified Conditioning Followed By Early Tapering Immunosuppressants and DLI In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory/Recurrent T Lymphoblastic Lymphoma

Min Dai, Hongsheng Zhou, Fen Huang, Yu Zhang, Zhiping Fan, Xutao Guo, M.D., Na Xu, Jing Sun, MD, Qifa Liu, MD

Blood (2013) 122 (21): 2122.

https://doi.org/10.1182/blood.V122.21.2122.2122

Published: 2013

Journal Articles

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Eva Maria Wagner, MD, Daniela Wehler, MD, Timo Schmitt, MD, Aline N. Lay, Karin Kolbe, MD, Matthias Theobald, MD, PhD, Wolfgang Herr, MD, Ralf G Meyer, MD

Blood (2013) 122 (21): 4526.

https://doi.org/10.1182/blood.V122.21.4526.4526

Published: 2013

Journal Articles

Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

Fatima Khan, MBBS, Michael A. Linden, MD, PhD, Nicole D. Zantek, M.D., Ph.D., Gregory M Vercellotti

Blood (2013) 122 (21): 5495.

https://doi.org/10.1182/blood.V122.21.5495.5495

Published: 2013

Journal Articles

A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease

Alex F. Herrera, MD, Haesook T. Kim, PhD, Bhavjot Bindra, Edwin P. Alyea, MD, Philippe Armand, MD, PhD, Corey S. Cutler, MD, Vincent T. Ho, MD, Jerome Ritz, MD, Bruce R. Blazar, MD, Joseph H. Antin, MD, Robert J. Soiffer, MD, John Koreth, MBBS, DPhil

Blood (2013) 122 (21): 909.

https://doi.org/10.1182/blood.V122.21.909.909

Published: 2013

Journal Articles

Sequential Intensiﬁed Conditioning Followed By Tapering Of Prophylactic Immunosupressants and Donor Lymphocyte Infusions In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory Leukemia

Qifa Liu, M.D., Li Xuan, Yu Zhang, Hongsheng Zhou, Fen Huang, MD, Min Dai, Yonghua Li, Danian Nie, MD, Na Xu, Xutao Guo, M.D., Dongjun Lin, Yang Xiao, MD, Can Liu, Ph.D, Qianli Jiang, Jing Sun, MD

Blood (2013) 122 (21): 702.

https://doi.org/10.1182/blood.V122.21.702.702

Published: 2013

Journal Articles

Sirolimus, Tacrolimus and Low-Dose Methotrexate Based Graft-Versus-Host Disease (GVHD) Prophylaxis After Non-Ablative or Reduced Intensity Conditioning in Related and Unrelated Donor Allogeneic Stem Cell Transplantation: Decreased Severe Early aGVHD but Persistence of Late Acute Gvhd

Ceberio Izaskun, Sean Devlin, PhD, Craig S. Sauter, MD, Juliet N Barker, MBBS, (Hons), FRACP, Hugo Castro-Malaspina, MD, Sergio A Giralt, MD, Doris M Ponce, MD, Lauren Lechner, Anne Marie R Gonzales, Jenna D Goldberg, MD, Miguel-Angel Perales, MD

Blood (2012) 120 (21): 4194.

https://doi.org/10.1182/blood.V120.21.4194.4194

Published: 2012

Journal Articles

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

Phillip Scheinberg, MD, Olga Nunez, RN, Priscila Scheinberg, MS, CCRP, Barbara Weinstein, RN, Colin O. Wu, PhD, Neal S. Young, MD

Blood (2011) 118 (21): 2406.

https://doi.org/10.1182/blood.V118.21.2406.2406

Published: 2011

Journal Articles

Duration of Corticosteroid Tapering as First Line Treatment In Idiopathic Thrombocytopenic Purpura.

Selay Lam, BSc, MD, Cyrus C. Hsia, BSc, MD, FRCPC

Blood (2010) 116 (21): 3688.

https://doi.org/10.1182/blood.V116.21.3688.3688

Published: 2010

Journal Articles

The Oral Iron Chelator Deferasirox for Treatment of Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation Does Not Appear to Interfere with the Calcineurin Inhibitor Cyclosporin Trough Serum Levels

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Alexia Nass, Sandra Otto, Gesine Bug, Nicolaus Kroeger, Uwe Platzbecker, Michael Stadler, MD, Katharina de Haas, MD, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1826.

https://doi.org/10.1182/blood.V116.21.1826.1826

Published: 2010

Journal Articles

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Vincent Ho, MD, Glenn Dranoff, MD, Haesook Kim, PhD, Matthew Vanneman, Mildred Pasek, Corey Cutler, MD, John Koreth, MBBS, Edwin Alyea, MD, Joseph H Antin, MD, Ritz Jerome, MD, Robert J Soiffer, MD

Blood (2008) 112 (11): 825.

https://doi.org/10.1182/blood.V112.11.825.825

Published: 2008

Journal Articles

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Eva Distler, Simone Thomas, Elke Schuerer, Cedrik Britten, Martin Schuler, Christoph Huber, Karin Kolbe, Thomas Woelfel, Ralf Meyer, Wolfgang Herr

Blood (2007) 110 (11): 4993.

https://doi.org/10.1182/blood.V110.11.4993.4993

Published: 2007

NARROW

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study

Extracorporeal Photopheresis Is Effective in Treating Graft-Versus-Host Disease: A Retrospective Analysis

Predictors for Steroid Tapering in Patients with Acute Graft-Versus-Host Disease and Their Impact on Graft-Versus-Host Disease Response and Non-Relapse Mortality: Older Age and Co-Morbidities Are Associated with Quicker Tapering and Worse Outcomes

Plasma Exchange Taper for Acquired TTP Is Protective Against Recurrence at Both 30 Days and 6 Months: A Retrospective Study from 2 Academic Medical Centers

Tapering Eltrombopag in Patients with Chronic ITP: How Successful Is This and in Whom Does It Work?

A Bayesian, Phase II Randomized Trial of Extracorporeal Photopheresis (ECP) Plus Steroids Versus Steroids-Alone in Patients with Newly Diagnosed Acute Graft Vs. Host Disease (GVHD): The Addition of ECP Improves Gvhd Response and the Ability to Taper Steroids

Immunosuppression Taper to Induce Graft-Verus-Tumor Activity As the Sole Therapy for Early Relapse after Reduced Intensity Allogeneic Hematopoietic Cell Transplantation

A Final Analysis of a Phase 2, Single-Arm Study of Platelet (Plt) Responses and Remission Rates in Patients with Immune Thrombocytopenia (ITP) Receiving Romiplostim

Sequential Intensified Conditioning Followed By Early Tapering Immunosuppressants and DLI In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory/Recurrent T Lymphoblastic Lymphoma

Follow Up On CD8-Depleted Donor-Lymphocyte Infusions After T-Cell Depleted Allogeneic Hemopoietic Stem Cell Transplantation

Bortezomib Is Highly Effective For Pure Red Cell Aplasia After ABO-Incompatible Hematopoietic Stem Cell Transplantation

A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease

Sequential Intensiﬁed Conditioning Followed By Tapering Of Prophylactic Immunosupressants and Donor Lymphocyte Infusions In Allogeneic Hematopoietic Stem Cell Transplantation For Refractory Leukemia

Sirolimus, Tacrolimus and Low-Dose Methotrexate Based Graft-Versus-Host Disease (GVHD) Prophylaxis After Non-Ablative or Reduced Intensity Conditioning in Related and Unrelated Donor Allogeneic Stem Cell Transplantation: Decreased Severe Early aGVHD but Persistence of Late Acute Gvhd

Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia

Duration of Corticosteroid Tapering as First Line Treatment In Idiopathic Thrombocytopenic Purpura.

The Oral Iron Chelator Deferasirox for Treatment of Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation Does Not Appear to Interfere with the Calcineurin Inhibitor Cyclosporin Trough Serum Levels

GM-CSF Secreting Leukemia Cell Vaccination after Allogeneic Reduced Intensity Hematopoietic Stem Cell Transplantation for Advanced Myeloid Malignancies

Graft-Versus-Host Disease or Infection: Rapid Detection of HLA Mismatch-Reactive T Cells Ex Vivo Can Facilitate Diagnosis and Guide Therapy after Allogeneic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only